Search research articles
Contact Us
Filters
Showing results (31-40 of 235) with videos related to
Page
of 24
Sort By:
Aging
|
November 12, 2010
The p53 inducing drug dosage may determine quiescence or senescence
David P Lane, Chandra Verma, Cheok Chit Fang
The Journal of Pathology
|
July 20, 2019
Intratumour heterogeneity of p53 expression; causes and consequences
Yuezhen Xue, Boris San Luis, David P Lane
Cell Cycle (Georgetown, Tex.)
|
August 3, 2007
HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophy
Anwesha Dey, Sheng-Hao Chao, David P Lane
Molecular Cancer Research : MCR
|
November 21, 2007
Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin-induced apoptosis: a potent drug combination
Chit Fang Cheok, Anwesha Dey, David P Lane
Plos One
|
December 11, 2013
Mapping the structural and dynamical features of multiple p53 DNA binding domains: insights into loop 1 intrinsic dynamics
Suryani Lukman, David P Lane, Chandra S Verma
Drug Discovery Today
|
June 22, 2016
Stapled peptide design: principles and roles of computation
Yaw Sing Tan, David P Lane, Chandra S Verma
Journal of the American Chemical Society
|
September 20, 2008
Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2
Shubhra Ghosh Dastidar, David P Lane, Chandra S Verma
Mini Reviews in Medicinal Chemistry
|
April 18, 2003
The p53-Mdm2 pathway: targets for the development of new anticancer therapeutics
Daniella I Zheleva, David P Lane, Peter M Fischer
Cell Cycle (Georgetown, Tex.)
|
January 17, 2008
Regulation of the p14ARF promoter by DNA methylation
Vinay Badal, Sergio Menendez, David Coomber, et al.
BMC Bioinformatics
|
December 5, 2009
Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100
Shubhra Ghosh Dastidar, David P Lane, Chandra S Verma
Page
of 24
Search research articles
Search
Showing results (31-40 of 235) with videos related to
Sort By:
Page
of 24
Aging
|
November 12, 2010
The p53 inducing drug dosage may determine quiescence or senescence
David P Lane, Chandra Verma, Cheok Chit Fang
The Journal of Pathology
|
July 20, 2019
Intratumour heterogeneity of p53 expression; causes and consequences
Yuezhen Xue, Boris San Luis, David P Lane
Cell Cycle (Georgetown, Tex.)
|
August 3, 2007
HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophy
Anwesha Dey, Sheng-Hao Chao, David P Lane
Molecular Cancer Research : MCR
|
November 21, 2007
Cyclin-dependent kinase inhibitors sensitize tumor cells to nutlin-induced apoptosis: a potent drug combination
Chit Fang Cheok, Anwesha Dey, David P Lane
Plos One
|
December 11, 2013
Mapping the structural and dynamical features of multiple p53 DNA binding domains: insights into loop 1 intrinsic dynamics
Suryani Lukman, David P Lane, Chandra S Verma
Drug Discovery Today
|
June 22, 2016
Stapled peptide design: principles and roles of computation
Yaw Sing Tan, David P Lane, Chandra S Verma
Journal of the American Chemical Society
|
September 20, 2008
Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2
Shubhra Ghosh Dastidar, David P Lane, Chandra S Verma
Mini Reviews in Medicinal Chemistry
|
April 18, 2003
The p53-Mdm2 pathway: targets for the development of new anticancer therapeutics
Daniella I Zheleva, David P Lane, Peter M Fischer
Cell Cycle (Georgetown, Tex.)
|
January 17, 2008
Regulation of the p14ARF promoter by DNA methylation
Vinay Badal, Sergio Menendez, David Coomber, et al.
BMC Bioinformatics
|
December 5, 2009
Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100
Shubhra Ghosh Dastidar, David P Lane, Chandra S Verma
Page
of 24